BTC/USD $68,420 +2.8%
ETH/USD $3,540 +1.4%
SOL/USD $142.80 -0.6%
BNB/USD $605.20 +0.9%
XRP/USD $0.62 -1.2%
DOGE/USD $0.18 +5.4%
BTC/USD $68,420 +2.8%
ETH/USD $3,540 +1.4%
SOL/USD $142.80 -0.6%
BNB/USD $605.20 +0.9%
XRP/USD $0.62 -1.2%
DOGE/USD $0.18 +5.4%
Markets

Buying Anthropic early? Check what you actually own

Anthropic is heading toward its expected Nasdaq debut Thursday, Nov. 19. Crypto investors looking for an early position have a more basic question to answer before deciding what to pay. What,

AnonymousCryptoCompass newsroom
November 18, 2026
7 min read
NEWS
Buying Anthropic early? Check what you actually own
CryptoCompass editorial visual for markets coverage.

Anthropic is heading toward its expected Nasdaq debut Thursday, Nov. 19.

Crypto investors looking for an early position have a more basic question to answer before deciding what to pay.

What, exactly, are they buying?

On one platform, an order can lead to regular stock.

On another, it buys a token backed by shares held elsewhere.

Related: Anthropic IPO token offer shuts out U.S. investors

A leveraged trading contract delivers no shares at all. The names look similar. The rights and risks do not.

  • Anthropic's proposed stock ticker is ANT. Its preliminary offering range was $70 to $78 a share.
  • Bitget offers both an IPO-linked token and a separate leveraged trading contract. They are not the same investment.
  • Kraken's tokenized IPO request window has closed. Its U.S. brokerage separately plans to offer regular shares after trading begins.
  • Fees, delivery dates and country restrictions differ. None of these routes guarantees a first-day profit.
Stock, share-backed tokens and perpetuals give investors different rights. Graphic by TheStreet Roundtable. Sources: Bitget, Kraken and Ondo.

When Anthropic is expected to start trading

Anthropic filed its public registration statement on Oct. 26. This is separate from the exchange products using its name.

The company's Nov. 10 roadshow announcement set a preliminary range of $70 to $78 for 825 million shares. That range does not promise what a buyer will pay once trading starts.

Fidelity's participant guide scheduled pricing for Wednesday evening, Nov. 18.

Kraken lists the expected Nasdaq debut as Thursday, Nov. 19, subject to market conditions. The first Nasdaq trade can be above or below the offering price.

Allocation's CEO previously explained to TheStreet Roundtable how perpetual futures on pre-IPO shares like Anthropic work, and how they differ from owning the stock. Watch the conversation from our archives below.

Anthropic futures aren't shares, Allocations CEO says (3:12)

What the near-$98 quotes actually mean

  • Bitget's contract was near $98. Its ANTUSDT perpetual traded at 97.82 USDT at about 5 p.m. ET on Nov. 18. USDT is a digital token designed to track the dollar.
  • OKX showed a similar price. Its Anthropic perpetual quoted a last trade of 97.86 USDT at the same time.
  • Note: Those are not stock trades. A perpetual is a derivative contract that lets traders take a position on price movements. It does not give the buyer an IPO allocation or ownership of Anthropic shares.

Research firm Allium's Nov. 18 report put a normalized Nov. 17 price at $97.22 a share and warned that liquidity was thin. A small amount of buying or selling can move a thin market sharply.

What Bitget's IPO offer actually delivers

Bitget's IPO Prime program is separate from its perpetual futures market. Successful subscribers receive rANT tokens linked to underlying Anthropic shares held through brokerage and custody partners.

  • The public round charges 5%. Bitget's release set a $100 minimum and a $25,000 individual commitment limit. The VIP round carries a 12% fee and a $3 million individual limit.
  • Fees apply to the allocation. Bitget's product guide says the underwriting fee applies to the amount allocated, not the entire amount requested. Unallocated funds are returned. On $1,000 of allocated exposure, those rates mean $50 in the public round or $120 in the VIP round. Those are access charges, before any later trading costs.
  • Allocation is uncertain. Investors can receive all, part or none of their requested exposure. The amount requested is not a guaranteed number of shares.
  • Delivery differs by round. Public-round delivery is targeted for IPO day. VIP delivery is expected three to five working days after the IPO, which could prevent an immediate first-day sale.
  • The $103 figure is not the offer price. Bitget labels it a reference estimate. Subscriptions are based on the final IPO price and applicable fees.
  • rANT is not directly owned stock. Holding it does not automatically confer shareholder status or voting rights. Custody, redemption and other rights depend on the product documents.
  • The subscription had a deadline. The public round was scheduled to close at 3 a.m. ET on the day before the actual IPO date. The product is for eligible users outside the U.S., subject to regional restrictions.
Access charges on $1,000 of allocated exposure, before other applicable costs. Graphic by TheStreet Roundtable. Sources: Bitget and Kraken.

Bitget's trading contract is a different deal

  • The payout is in USDT, not shares. ANTUSDT offers synthetic price exposure. Gains and losses are settled in USDT rather than Anthropic stock.
  • Leverage can wipe out a position. Bitget's public contract settings showed a maximum of 20 times leverage when checked Nov. 18. An adverse move can exhaust the money supporting a position and trigger its forced closure.
  • There can be costs beyond the trade. Perpetuals can charge periodic funding payments between traders. Trading fees and funding are separate from IPO Prime's allocation fees.

Bitget scheduled a Nov. 17 adjustment that divided the old contract's unit price by 13.1160 and changed its name from ANTHROPICUSDT to ANTUSDT.

How Kraken and Ondo differ 

  • Kraken's ANTx is share-backed, but not a share. Its terms describe one-to-one backing and a 5% spread on allocated exposure. Holders do not directly own the underlying stock or receive voting rights. A $1,000 allocation therefore carries a $50 spread.
  • Kraken requests have closed. Its current IPO page gives a noon ET Nov. 18 deadline. Allocations can be full, partial or zero. The tokenized offer excludes U.S. persons and several other markets.
  • U.S. customers have a separate route. Kraken's U.S. page says Kraken Securities plans to offer regular ANT shares from the first trading day. Buyers would pay the live market price, not receive a pre-IPO allocation. State and account restrictions apply.
  • Ondo plans day-one tokens. Its announcement says ANTon will launch when Anthropic begins Nasdaq trading, starting at $1 for eligible non-U.S. users. It advertises no minting fee, with network costs still payable.
  • Ondo is not distributing IPO shares. ANTon provides economic exposure backed by stock and cash in transit. It gives no right to receive the underlying shares. Ondo says it is not affiliated with Anthropic or participating in the IPO.
  • Around-the-clock access has limits. Ondo plans 24/7 creation and redemption of ANTon, including weekends, subject to maintenance and other interruptions. Country restrictions still apply.

What to check before placing an order

  • Read the product name. ANT stock, rANT, ANTx, ANTon and ANTUSDT are different instruments, even when they follow the same company.
  • Check what you can sell and when. An allocation, a delivered token and an open derivative position can have different settlement and exit rules.
  • Add the costs. Compare allocation fees, trading fees, funding, spreads and network charges. A price chart alone does not show the total expense.
  • Check eligibility before funding. A platform's global website does not mean every product is available in every state or country.

For a U.S. reader who wants actual Anthropic stock, the relevant route is a regular brokerage order after listing, not a non-U.S. token allocation.

For eligible buyers elsewhere, the question is what the token gives them and what it costs to get out. TheStreet previously covered Kraken's offer and its U.S. restrictions.

Disclaimer: This article is for informational purposes only and is not financial advice. Consult a qualified financial adviser before making any investment decision.